Literature DB >> 22825356

Loss of HITS (FAM107B) expression in cancers of multiple organs: tissue microarray analysis.

Hideo Nakajima1, Keita Koizumi, Takuji Tanaka, Yasuhito Ishigaki, Yoshino Yoshitake, Hideto Yonekura, Tsutomu Sakuma, Toshihiro Fukushima, Hisanori Umehara, Soichiro Ueno, Toshinari Minamoto, Yoshiharu Motoo.   

Abstract

Family with sequence similarity 107 (FAM107) proteins consist of two subtypes, FAM107A and FAM107B in mammals, possessing a conserved N-terminal domain of unknown function. Recently we found that FAM107B, an 18 kDa nuclear protein, is expressed in a broad range of tissues and is downregulated in gastrointestinal cancer. Because FAM107B expression is amplified by heat-shock stimulation, we designated it heat shock-inducible tumor small protein (HITS). Although data related to FAM107A as a candidate tumor suppressor have been accumulated, little biological information is available for HITS. In the present study, we examined HITS expression using immunohistochemistry with tissue microarrays and performed detailed statistical analyses. By screening a high-density multiple organ tumor and normal tissue microarray, HITS expression was decreased in tumor tissues of the breast, thyroid, testis and uterine cervix as well as the stomach and colon. Further analysis of tissue microarrays of individual organs showed that loss of HITS expression in cancer tissues was statistically significant and commonly observed in distinct organs in a histological type-specific manner. The HITS expression intensity was inversely correlated with the primary tumor size in breast and thyroid cancers. In addition, effects of tetracycline-inducible HITS expression on tumor growth were investigated in vivo. Forced expression of HITS inhibited tumor xenograft proliferation, compared with the mock-treated tumor xenograft model. These results show that loss of HITS expression is a common phenomenon observed in cancers of distinct organs and involved in tumor development and proliferation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22825356     DOI: 10.3892/ijo.2012.1550

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  3 in total

1.  Measuring body composition using the bioelectrical impedance method can predict the outcomes of gemcitabine-based chemotherapy in patients with pancreatobiliary tract cancer.

Authors:  Mami Muramatsu; Aya Tsuchiya; Seiko Ohta; Yukie Iijima; Miyuki Maruyama; Yoshiko Onodera; Megumi Hagihara; Naoki Nakaya; Itaru Sato; Kenji Omura; Soichiro Ueno; Hideo Nakajima
Journal:  Oncol Lett       Date:  2015-10-16       Impact factor: 2.967

2.  Family with sequence similarity 107: A family of stress responsive small proteins with diverse functions in cancer and the nervous system (Review).

Authors:  Hideo Nakajima; Keita Koizumi
Journal:  Biomed Rep       Date:  2014-02-27

3.  Oral vitamin D supplementation induces transcriptomic changes in rectal mucosa that are linked to anti-tumour effects.

Authors:  P G Vaughan-Shaw; G Grimes; J P Blackmur; M Timofeeva; M Walker; L Y Ooi; Victoria Svinti; Kevin Donnelly; F V N Din; S M Farrington; M G Dunlop
Journal:  BMC Med       Date:  2021-08-03       Impact factor: 8.775

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.